RE:exactly 1 yr ago...I'm frustrated as well but that's not a fair characterization.
BTD in Feb.
Favourable trial design confirmed by FDA in June.
Debenture extended in July.
Told publicly for the first time (I think?) by CEO in September when to expect a deal by.
October: debenture conversion.
Plenty to be frustrated about, but no need to lie about what has occurred thus far in the year.